Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT02238535
Eligibility Criteria:
Inclusion Criteria:
* Patients with pulmonary embolism after undergone surgical treatment (intravascular thrombolysis, catheter thrombus fragmentation)
* Patients with preserved thromboembolism in the pulmonary circulation system and mean pressure in the pulmonary artery of more than 25 mm Hg
Exclusion Criteria:
* Patient did not sign the informed consent.
* Mean pulmonary artery pressure after surgical treatment less than 25 mm Hg
* Age above 75 years.
* Patients with an increased risk of bleeding - including gastric ulcer and 12 duodenal ulcer in acute, hemorrhagic stroke.
* Severe coronary artery disease (unstable angina, myocardial infarction within the last 6 months).
* Acute heart failure or CHF IV in NYHA.
* Severe arrhythmias.
* Pregnancy, lactation.
* The presence of severe diseases of other organ systems that may result in death during the first year after surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02238535
Study Brief:
Protocol Section:
NCT02238535